1. Home
  2. KNSL vs QGEN Comparison

KNSL vs QGEN Comparison

Compare KNSL & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kinsale Capital Group Inc.

KNSL

Kinsale Capital Group Inc.

N/A

Current Price

$399.36

Market Cap

8.9B

Sector

Finance

ML Signal

N/A

QGEN

Qiagen N.V.

N/A

Current Price

$49.40

Market Cap

9.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KNSL
QGEN
Founded
2009
1986
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.9B
9.0B
IPO Year
2016
1998

Fundamental Metrics

Financial Performance
Metric
KNSL
QGEN
Price
$399.36
$49.40
Analyst Decision
Hold
Hold
Analyst Count
12
12
Target Price
★ $354.56
$49.77
AVG Volume (30 Days)
244.4K
★ 5.2M
Earning Date
10-22-2026
11-04-2026
Dividend Yield
0.25%
★ 5.56%
EPS Growth
★ 21.77
N/A
EPS
★ 16.97
N/A
Revenue
★ $1,873,987,000.00
N/A
Revenue This Year
$3.76
$2.21
Revenue Next Year
N/A
$5.11
P/E Ratio
★ $23.31
$24.01
Revenue Growth
★ 18.04
N/A
52 Week Low
$287.20
$32.53
52 Week High
$421.90
$57.82

Technical Indicators

Market Signals
Indicator
KNSL
QGEN
Relative Strength Index (RSI) 61.15 52.81
Support Level $349.06 $47.37
Resistance Level $405.41 $49.86
Average True Range (ATR) 10.80 0.25
MACD 0.01 -0.34
Stochastic Oscillator 77.88 1.81

Price Performance

Historical Comparison
KNSL
QGEN

About KNSL Kinsale Capital Group Inc.

Kinsale Capital Group Inc is an insurance holding company. The company is engaged in offering property, casualty, and specialty insurance products. It offers specialty insurance products for allied health, healthcare, life sciences, professional, and a public entity. The company operates in only one reportable segment which is the Excess and Surplus Lines Insurance segment, which includes commercial excess and surplus lines liability and property insurance products through its underwriting divisions. The company generates revenues in the form of premiums and investment income.

About QGEN Qiagen N.V.

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables, with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by Europe, the Middle East, and Africa (33%) and Asia-Pacific (15%).

Share on Social Networks: